Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Novel low molecular weight anti-HIV agents by Merck & Co.

Nov. 4, 2004

Tipranavir/ritonavir shows antiviral efficacy in advanced HIV disease

Nov. 3, 2004

Chemokine CCR5 inhibitor provides potent protection from vaginal SHIV transmission

Oct. 28, 2004

Merck researchers describe new anti-HIV vaccines

Oct. 27, 2004

Gilead Sciences discontinues development of GS-9005 and GS-7340

Oct. 25, 2004

Tibotec describes two series of anti-HIV agents

Oct. 22, 2004

New phase III study for Ushercell in HIV

Oct. 21, 2004

Traditional approval for Fuzeon

Oct. 20, 2004

Encouraging interim results from phase I study of ACP-HIP

Oct. 19, 2004

Potential clinical effects reported for the HIV-1 integrase inhibitor L-870810

Oct. 19, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
XPC-837 restores network dysfunction in Dravet syndrome models
BioWorld Science
Researchers from Xenon Pharmaceuticals Inc. described the preclinical efficacy of XPC-837 in models of Dravet syndrome, a severe developmental and epileptic...